Email alerts
Advanced Search
  • Aug 27, 2014
    Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy
    Post-Market Clinical Trial Will Assess Superiority of the AdaptivCRT® Feature Compared to Standard CRT

    MINNEAPOLIS - Aug. 27, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including patient...

  • Aug 26, 2014
    Medtronic Acquires Sapiens Steering Brain Stimulation
    Sapiens' Deep Brain Stimulation Technologies Strengthen Medtronic's Neuromodulation Portfolio and Neuroscience Leadership Position

    MINNEAPOLIS and EINDHOVEN - Aug. 26, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep...

  • Aug 26, 2014
    Announcement under Irish Takeover Rules Relevant Securities in Issue – August 26, 2014

    DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 26, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...

  • Aug 25, 2014
    Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.
    AdaptivCRT® Algorithm Customizes Therapy for Heart Failure Patients and Improves Their Response Rates

    MINNEAPOLIS - Aug. 25, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva®...

  • Aug 22, 2014
    Covidien Acquires Reverse Medical Corporation
    Generates Opportunity to Leverage Existing Vascular Technologies and Customer Relationships to Drive Increased Market Penetration

    DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 22, 2014-- Covidien plc (NYSE:COV) today announced it has acquired Reverse Medical Corporation, a privately held medical device company focused on expanding...

Show 5102550100 per page